Evidence map›Paper›PMID 31014009›Full record

ArticleMolecules (Basel, Switzerland)2019

Selenocompounds as Novel Antibacterial Agents and Bacterial Efflux Pump Inhibitors.

Tímea Mosolygó, Annamária Kincses, Andrea Csonka, Ádám Szabó Tönki, Karolina Witek, Carmen Sanmartín, Małgorzata Anna Marć, Jadwiga Handzlik, Katarzyna Kieć-Kononowicz, Enrique Domínguez-Álvarez and 1 more

Open access · goldAbstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
3.4field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 34 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Review
  11. Review
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Inhibition-Disruption ofMicroorganisms · 2019
    Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 3 countries.

Tímea MosolygóDepartment of Medical Microbiology and Immunobiology, Faculty of Medicine, University of Szeged, Dóm tér 10, 6720 Szeged, Hungary. mosolygo.timea@med.u-szeged.hu.ORCID 0000-0002-4499-388X
Annamária KincsesDepartment of Medical Microbiology and Immunobiology, Faculty of Medicine, University of Szeged, Dóm tér 10, 6720 Szeged, Hungary. kincses.annamaria@med.u-szeged.hu.
Andrea CsonkaDepartment of Medical Microbiology and Immunobiology, Faculty of Medicine, University of Szeged, Dóm tér 10, 6720 Szeged, Hungary. csonka.andrea83@gmail.com.
Ádám Szabó TönkiDepartment of Medical Microbiology and Immunobiology, Faculty of Medicine, University of Szeged, Dóm tér 10, 6720 Szeged, Hungary. szabotadam@gmail.com.
Karolina WitekDepartment of Technology and Biotechnology of Drugs, Jagiellonian University Medical College, Medyczna 9, 30-688 Kraków, Poland. karolina.witek@uj.edu.pl.
Carmen SanmartínDepartment of Pharmaceutical Technology and Chemistry, School of Pharmacy and Nutrition, University of Navarra, Irunlarrea 1, 31008 Pamplona, Spain. sanmartin@unav.es.
Małgorzata Anna MarćDepartment of Technology and Biotechnology of Drugs, Jagiellonian University Medical College, Medyczna 9, 30-688 Kraków, Poland. marcmalgorzata@gmail.com.
Jadwiga HandzlikDepartment of Technology and Biotechnology of Drugs, Jagiellonian University Medical College, Medyczna 9, 30-688 Kraków, Poland. j.handzlik@uj.edu.pl.
Katarzyna Kieć-KononowiczDepartment of Technology and Biotechnology of Drugs, Jagiellonian University Medical College, Medyczna 9, 30-688 Kraków, Poland. mfkonono@cyf-kr.edu.pl.
Enrique Domínguez-ÁlvarezInstituto de Química Orgánica General (IQOG-CSIC), Consejo Superior de Investigaciones Científicas, Juan de la Cierva 3, 28006 Madrid, Spain. e.dominguez-alvarez@iqog.csic.es.ORCID 0000-0003-2655-1575
Gabriella SpenglerDepartment of Medical Microbiology and Immunobiology, Faculty of Medicine, University of Szeged, Dóm tér 10, 6720 Szeged, Hungary. spengler.gabriella@med.u-szeged.hu.
University of Szeged · HUJagiellonian University · PLConsejo Superior de Investigaciones Científicas · ESNavarre Institute of Health Research · ES

Funding

Consejo Superior de Investigaciones Científicas 201780I027Emberi Eroforrások Minisztériuma ÚNKP-17-3Magyar Tudományos Akadémia GINOP-2.3.2-15-2016-00038Szegedi Tudományegyetem SZTE ÁOK-KKA 2018/270-62-2
6 · The paper itself

Abstract

Bacterial multidrug resistance is becoming a growing problem for public health, due to the development and spreading of bacterial strains resistant to antimicrobials. In this study, the antibacterial and multidrug resistance reversing activity of a series of seleno-carbonyl compounds has been evaluated. The effects of eleven selenocompounds on bacterial growth were evaluated in

Indexed as

Anti-Bacterial AgentsSelenium CompoundsChlamydia trachomatisDrug Resistance, Multiple, BacterialEnterococcus faecalisEscherichia coliMethicillin-Resistant Staphylococcus aureusMicrobial Sensitivity TestsStaphylococcal InfectionsAnti-Bacterial AgentsSelenium CompoundsAcrAB-TolC efflux pumpChlamydia trachomatis DEscherichia coli K-12 AG100selenocompoundsselenoestersStaphylococcus aureus

Identifiers

PMID31014009
PMCPMC6514980
OpenAlexW2936423571

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.